Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 70771-1485

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 70771-1485). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

80 mg/ 12.5 mg (1e3318d3 0dba 4f48 8bd1 0ce09cde403d 05)

FDA Label Image

160 mg/ 12.5 mg (1e3318d3 0dba 4f48 8bd1 0ce09cde403d 06)

160 mg/ 12.5 mg (1e3318d3 0dba 4f48 8bd1 0ce09cde403d 06)
This is a medication for treating high blood pressure that contains the active ingredients Valsartan and Hydrochlorothiazide. It comes in a film-coated tablet form and should be stored at room temperature. The tablets are dispensed in a tightly closed container. The manufacturer is listed as 2ydus CosiaFeatpcar L.*
FDA Label Image

160 mg/ 25 mg (1e3318d3 0dba 4f48 8bd1 0ce09cde403d 07)

160 mg/ 25 mg (1e3318d3 0dba 4f48 8bd1 0ce09cde403d 07)
This is a prescription medicine called Valsartan and Hydrochlorothiazide tablets. It contains 60 mg of Valsartan and 25 mg of Hydrochlorothiazide. The tablets are produced by Cadila Healthcare Ltd. in India. The text includes instructions to dispense the drug in a tightly closed container and keep it out of reach of patients. Patient information is provided separately.*
FDA Label Image

320 mg/ 12.5 mg (1e3318d3 0dba 4f48 8bd1 0ce09cde403d 08)

320 mg/ 12.5 mg (1e3318d3 0dba 4f48 8bd1 0ce09cde403d 08)
This text is a description of a medication called Valsartan and Hydrochlorothiazide tablets. It is a prescription drug that may only be dispensed by a pharmacist. The tablets contain 320 milligrams of Valsartan and 125 milligrams of Hydrochlorothiazide. The dosage should be followed as prescribed by the doctor. The medication should be stored at a temperature of 20° to 55°C (68° to 157°F) and kept in a closed container to protect it from moisture. This drug should be kept out of the reach of children. The manufacturer of the drug is Cadia Healthcare Ltd located in Ahmedabad, India.*
FDA Label Image

320 mg/ 25 mg (1e3318d3 0dba 4f48 8bd1 0ce09cde403d 09)

320 mg/ 25 mg (1e3318d3 0dba 4f48 8bd1 0ce09cde403d 09)
This is a description of Valsartan and Hydrochlorothiazide tablets, USP. The tablets are film-coated and contain 320mg of Valsartan and 25mg of Hydrochlorothiazide, USP. The usual dosage is provided in the package insert for complete prescribing information. The drug should be stored between 20°C to 25°C (68°F to 77°F) and must be protected from moisture. The tablets need to be dispensed in a tightly closed container and kept out of the reach of children. It is manufactured by Cadia Healthcare Ltd in Abmedabad, India. Patient information for the drug is provided separately.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.